Tirzepatide even takes it a step further by also mimicking another gut hormone called GIP (Glucose-dependent Insulinotropic Polypeptide), creating a dual-action effect that has shown even greater efficacy for both blood sugar control and weight loss in clinical trials
Still, Longacre believes more oversight is needed in the online marketplace
AOD9604 in 2026: Efficacy, Safety, and Regulatory Status from the Latest Evidence By Isaac Introduction AOD9604 is a synthetic peptide derived from the C-terminal fragment (amino acids 177191) of human growth hormone (hGH), specifically designed to mimic the lipolytic properties of hGH without its anabolic or hyperglycemic effects
Besides aiding weight loss, its active ingredient, semaglutide, also helps manage blood sugar levels and is approved for Type 2 diabetes under the brand names Ozempic and Rybelsus
3.2.3 Other cardiovascular integrations Beyond heart failure, TCM compounds are being explored in coronary artery disease and hypertension as adjuncts to standard care